Authors
Latest:
Implementation of Paperless Credentialing in a Multi-State Managed Care OrganizationInstitution of paperless credentialing is analyzed on a pre-/post-implementation basis to understand the impact on business and productivity.
Latest:
The Value of Value-Based Insurance Design: Savings From Eliminating Drug Co-PaymentsGeisinger Health System’s $0 co-pay drug program for its chronically ill employee population is associated with positive cost savings and a 5-year return-on-investment of approximately 1.8.
Latest:
Economic Outcomes of Insurer-Led Care Management for High-Cost Medicaid PatientsThis study evaluated economic outcomes of an insurer-led care management program for high-cost Medicaid patients using teams of community health care workers and nurses.
Latest:
Face Time Versus Test Ordering: Is There a Trade-off?Real-time location systems can capture face time and trade-offs between face time and diagnostic testing so that clinicians' responses to time pressures can be measured.
Latest:
Persistent High Utilization in a Privately Insured PopulationThis study describes the small number of individuals responsible for larger shares of healthcare cost persistently over a 3-year period.
Latest:
Clinical Characteristics and Treatment Patterns Among US Patients With HIVIt is important to take into account individual complexities such as comorbidities and pill burden when selecting antiretroviral therapy regimens for individuals living with HIV.
Latest:
Substitutive Hospital at Home for Older Persons: Effects on CostsSubstitutive Hospital at Home care for 4 common conditions is associated with cost savings.
Latest:
Using Simulation to Identify and Resolve Threats to Patient SafetyThe same simulation methodology used in the aviation industry was able to uncover latent environmental threats to patient safety.
Latest:
Availability of Prices for Shoppable Services on Hospital Internet SitesOnly 60% of hospitals display their cash prices and 5% display their minimum negotiated charges on their public websites; many hospitals are in violation of new federal legislation.
Latest:
Geographic Variation in Medicare Home Health ExpendituresThis study attempts to identify the sources of the significant 2.5-fold variation found in home health expenditures, a possible indicator of inefficiency and waste.
Latest:
Value-Based Arrangements May Be More Prevalent Than AssumedWe surveyed biopharmaceutical manufacturers and payers to understand the prevalence and characteristics of value-based payment arrangements, as well as their implementation obstacles and success factors.
Latest:
US Payer Perspectives on Evidence for Formulary Decision MakingTo improve formulary design processes and support payers in providing more effective healthcare, policy makers should consider involving commercial payers in the development of comparative effectiveness research and creation of research and treatment guidelines.
Latest:
Disease-Modifying Antirheumatic Drug Initiation Among Patients Newly Diagnosed With Rheumatoid ArthritisOnly slightly more than half of patients with newly diagnosed rheumatoid arthritis initiated therapy within 1 year.
Latest:
Measuring Migraine-Related Quality of Care Across 10 Health PlansStandardized measurement of migraine, an underdiagnosed and perhaps underrecognized condition, is necessary for health plans to understand utilization of costly diagnostic and treatment services.
Latest:
Simple Errors in Interpretation and Publication Can Be CostlyA recent AJMC study contained overstatements and small but importantly placed errors that have the potential to cause unwarranted on-the-ground cost problems.
Latest:
Widespread Adoption of Evidence-Based Practices Is Essential for a Growing Medicare PopulationWhen providers move from employing traditional practices to new methods that are steeped in evidence, this benefits patient health. The result is higher-quality, more affordable care, often stemming from lower rates of hospital infections, readmissions, and, in general, improved outcomes.
Latest:
Real-World Outcomes Among Patients With Early Rapidly Progressive Rheumatoid ArthritisThis study suggests that lower healthcare resource use and achieving low disease activity are associated with first-line abatacept compared with a first-line tumor necrosis factor-α inhibitor for patients with early rapidly progressive rheumatoid arthritis.
